L-asparaginase for treatment of childhood acute lymphoblastic leukemia: What have we learned? (Commentary on Schrey et al., page 378)

Abstract

Pediatric Blood & CancerVolume 57, Issue 3 p. 357-358 Highlight L-asparaginase for treatment of childhood acute lymphoblastic leukemia: What have we learned? (Commentary on Schrey et al., page 378) Barbara L. Asselin MD, Corresponding Author Barbara L. Asselin MD barbara_asselin@urmc.rochester.edu Department of Pediatrics, Golisano Children's Hospital at the University of Rochester Medical Center, Rochester, New YorkDepartment of Pediatrics, Box 667, Golisano Children's Hospital at the University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642.===Search for more papers by this author Barbara L. Asselin MD, Corresponding Author Barbara L. Asselin MD barbara_asselin@urmc.rochester.edu Department of Pediatrics, Golisano Children's Hospital at the University of Rochester Medical Center, Rochester, New YorkDepartment of Pediatrics, Box 667, Golisano Children's Hospital at the University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642.===Search for more papers by this author First published: 20 April 2011 https://doi.org/10.1002/pbc.23135Citations: 6Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume57, Issue3September 2011Pages 357-358 RelatedInformation